These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2873859)

  • 1. Beta-adrenoceptor-mediated modulation of calcium ionophore activated polymorphonuclear leucocytes.
    Mack JA; Nielson CP; Stevens DL; Vestal RE
    Br J Pharmacol; 1986 Jun; 88(2):417-23. PubMed ID: 2873859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation.
    Nielson CP
    J Immunol; 1987 Oct; 139(7):2392-7. PubMed ID: 2821113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
    Haynes JM; Hill SJ
    Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells.
    Lindén A
    Br J Pharmacol; 1996 Sep; 119(2):402-6. PubMed ID: 8886427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells.
    Drury DE; Chong LK; Ghahramani P; Peachell PT
    Br J Pharmacol; 1998 Jun; 124(4):711-8. PubMed ID: 9690863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic regulation of a myocardial actin gene via a cyclic AMP-independent pathway.
    Bishopric NH; Sato B; Webster KA
    J Biol Chem; 1992 Oct; 267(29):20932-6. PubMed ID: 1383212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
    Haynes JM
    Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.
    Gray DW; Marshall I
    Br J Pharmacol; 1992 Nov; 107(3):684-90. PubMed ID: 1335334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adrenoceptors involved in the electrogenic chloride secretion by cultured rat epididymal epithelium.
    Leung AY; Yip WK; Wong PY
    Br J Pharmacol; 1992 Sep; 107(1):146-51. PubMed ID: 1358380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    Chong LK; Cooper E; Vardey CJ; Peachell PT
    Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical response of rat myocardium to dibutyryl cyclic AMP in relation to effects of alpha-and beta-adrenoceptor stimulators.
    Skomedal T; Osnes JB; Oye I
    Acta Pharmacol Toxicol (Copenh); 1981 Aug; 49(2):81-91. PubMed ID: 6121455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood platelets decrease concentration of reactive oxygen species produced by polymorphonuclear leukocytes.
    Jancinova V; Drabikova K; Petrikova M; Nosal R
    Bratisl Lek Listy; 2004; 105(7-8):250-5. PubMed ID: 15543845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory actions of salmeterol on human airway macrophages and blood monocytes.
    Baker AJ; Palmer J; Johnson M; Fuller RW
    Eur J Pharmacol; 1994 Nov; 264(3):301-6. PubMed ID: 7698169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin and doxorubicinol-induced alterations in human polymorphonuclear leukocyte oxygen metabolite generation.
    Nielson CP; Brenner D; Olson RD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):19-25. PubMed ID: 3088258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible binding of a carbostyril-based agonist and antagonist to the beta-adrenoceptor in DDT1 MF-2 cells and rat aorta.
    Deyrup MD; Greco PG; Otero DH; Dennis DM; Gelband CH; Baker SP
    Br J Pharmacol; 1998 May; 124(1):165-75. PubMed ID: 9630356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism.
    Haskó G; Shanley TP; Egnaczyk G; Németh ZH; Salzman AL; Vizi ES; Szabó C
    Br J Pharmacol; 1998 Nov; 125(6):1297-303. PubMed ID: 9863660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-3 adrenergic stimulation of L-type Ca(2+) channels in rat portal vein myocytes.
    Viard P; Macrez N; Coussin F; Morel JL; Mironneau J
    Br J Pharmacol; 2000 Apr; 129(7):1497-505. PubMed ID: 10742307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation of Na+-dependent efflux of Ca2+ from liver mitochondria by glucagon and beta-adrenergic agonists.
    Goldstone TP; Duddridge RJ; Crompton M
    Biochem J; 1983 Feb; 210(2):463-72. PubMed ID: 6134523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.
    Priest RM; Hucks D; Ward JP
    Br J Pharmacol; 1997 Dec; 122(7):1375-84. PubMed ID: 9421285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.